Nano Biomedicine

Lung Cancer Risk in Passive Smokers using Salivary Exosome-Derived MicroRNAs

Yoshiya HASHIMOTO3, Koichi IMAI3,
and Kazuya TAKAHASHI2

1Graduate School of Dentistry (Geriatric Dentistry),
2Department of Geriatric Dentistry, 3Department of Biomaterials,
Osaka Dental University, Osaka, Japan

Nano Biomed 2018; 10(2): 69-76, (Dec 30, Nano Biomedicine)

The objective of this study was to investigate the lung cancer risk in passive smokers using salivary exosome-derived microRNAs (mirs). Individuals were confirmed to be passive smokers by inter-viewing them using the Kano Test for Social Nicotine Dependence (KTSND) and measuring exhaled breath carbon monoxide (eBCO) level. Unstimulated saliva samples were collected from 25 students, and exosomes were isolated from salivary supernatants. Total RNA was isolated from the isolated exosome and washed and spun repeatedly using a filter cartridge to obtain the total RNA. Digital PCR was performed using mir-22, mir-150, and mir-155, which are related to lung cancer; mir-191 was used as the endogenous control. Salivary exosome samples considered posi-tive by the carbon monoxide breath analysis monitor exhibited expression of mir-22, mir-150, and mir-155, that reportedly have increased expression in lung cancer. These findings indicate the pos-sibility of investigating lung cancer risk in passive smokers using salivary exosome-derived mirs.

Key words: carbon monoxide, microRNA, passive smoke, lung cancer risk, salivary exosomes

All documents in this paper (Free)